TOG Review (RCOG Journal)
MRCOG Part 2
Subfertility and Reproductive Medicine
Ovarian hyperstimulation syndrome
Key Statistics
- 1–5% — Moderate–severe OHSS, ART cycles
- <0.1% — Severe/critical OHSS, UK 2022–23 (HFEA, n=64)
- OR 0.26 — OHSS risk, cryopreservation vs fresh et
Don't-miss facts
-
PCOS = most important OHSS risk factor (up to 5× risk); high-risk markers: AMH >22.5 pmol/l, AFC >20, >17–19 follicles ≥11–12 mm at trigger
-
GnRH antagonist protocol recommended for at-risk patients – equal LBR, less OHSS (RR 0.63) vs agonist protocol
-
GnRH agonist trigger (antagonist cycles only): OR 0.15 for OHSS vs hCG, but cuts pregnancy rate if fresh ET follows – pair with freeze-all or low-dose hCG rescue
-
Embryo cryopreservation: OR 0.26 for OHSS, no LBR penalty – HFEA green-rated; use if E2 >3500 pg/mL or ≥20 oocytes
-
Cabergoline 0.5 mg/day ×8 days post-hCG trigger reduces OHSS (OR 0.32), no effect on pregnancy rate
-
NOT recommended: cycle cancellation, coasting, reduced-dose hCG trigger, calcium, albumin, luteal letrozole, luteal GnRH antagonist
-
Severe OHSS: haematocrit >0.45, Na <135, K >5, albumin <35 g/L; all severe/inpatient cases – commence LMWH
-
OHSS thrombosis often upper body – low threshold for suspicion with neck pain/visual loss/dizziness
Evidence tiers at a glance
Recommended: antagonist protocol, low starting dose, USS surveillance, GnRH agonist trigger, embryo cryopreservation, cabergoline
Not recommended: cancellation, coasting, reduced-dose hCG, metformin/aspirin (primary), calcium, albumin, luteal letrozole/antagonist
Abbreviation Key
- OHSS — ovarian hyperstimulation syndrome
- FSH — follicle-stimulating hormone
- ART — assisted reproductive technology
- E2 — estradiol
- hCG — human chorionic gonadotrophin
- ESHRE — European Society for Human Reproduction and Embryology
- GnRH — gonadotrophin-releasing hormone
- HFEA — Human Fertilisation and Embryology Authority
- VEGF — vascular endothelial growth factor
- LBR — live birth rate
- RAS — renin–angiotensin system
- ET — embryo transfer
- AMH — anti-Müllerian hormone
- FET — frozen embryo transfer
- AFC — antral follicle count
- ARDS — acute respiratory distress syndrome
- COS — controlled ovarian stimulation
- TSH — thyroid stimulating hormone
- PCOS — polycystic ovary syndrome
- SERM — selective estrogen receptor modulator
- LMWH — low molecular weight heparin
- VTE — venous thromboembolism
- TVUSS — transvaginal ultrasound scan
- ICU — intensive care unit
- LH — luteinising hormone
- AUC — area under the curve
Source: Bailie E, Jayaprakasan K, Gogna K, Richardson A. Ovarian hyperstimulation syndrome – risk reduction strategies. The Obstetrician & Gynaecologist 2025;27:142–153. doi:10.1111/tog.12975
MRCOG AI is an independent educational tool. It is not affiliated with, endorsed by, or connected to the Royal College of Obstetricians and Gynaecologists (RCOG).